Healthcare -
Biotechnology - NASDAQ - CH
$ 41.63
1.37 %
$ 3.6 B
Market Cap
-8.59
P/E
CRSP - NET INCOME
Net Income CRSP - CRISPR Therapeutics AG
-366 M
LAST VALUE
24.95%
2 YEAR CAGR
-45.31%
5 YEAR CAGR
-48.98%
10 YEAR CAGR